News

Jan 10
Update of the information about supplementary pensions

The FSMA website (available in French or Dutch only) and the FAQs (available in French or Dutch only) about supplementary pensions state a number of amounts that are set by the social legislation on supplementary pensions. These amounts have been updated. In addition, the following questions in the FAQs for employees have been updated as follows: When can I start collecting […]

Jan 10
Dogecoin creator slams Mozilla for pausing crypto donations

The creator of Dogecoin criticized Mozilla for supposedly making its decision based on feedback from the “ignorant, reactionary internet mob.” 1747 Total views 54 Total shares The Mozilla Foundation’s back-tracking on crypto has earned a reaction from the creator of the world’s first meme cryptocurrency. On Dec. 31, 2021, Mozilla, the developers of the Firefox […]

Jan 10
Was Friday USD Decline a Correction? Rate Markets Suggest it was

Despite relatively upbeat NFP report, the dollar was down on Friday. This is somewhat surprising as the odds of a Fed rate hike in March rose after the report. If before the report, the chances were 66%, then on Monday they rose to 70%:Currently the markets price in three rate hikes in 2021. It is […]

Jan 10
Market Spotlight: NZDCAD Trend Play

NZDCAD Looking To Break LowerNZDCAD has been moving in a broad bearish channel over the last year and price is now threatening to take another leg lower. NZD has been among the currencies hardest hit by the recent fall-back in risk appetite. Hawkish Fed expectations, fuelled by the December FOMC minutes last week, have spooked […]

Jan 10
Torrid Holdings shares sink after sales warning

Torrid Holdings Inc. CURV, -16.87% shares sank 9.5% in Monday premarket trading after the plus-size women’s fashion retailer issued a sales warning for the fourth quarter. The company now expects sales in the range of $300 million to $305 million, down from previous guidance of $325 million to $335 million. The FactSet consensus is for […]

Jan 10
Ocugen's stock gains 8% on promising COVID-19 booster data from partner Bharat Biotech

Shares of Ocugen Inc. OCGN, -1.69% were up 8.1% in premarket trading on Monday, two days after a preprint came out Friday outlining Phase 2 clinical trial results for a COVID-19 booster dose being developed by Bharat Biotech, a privately held biotech based in Hyderabad. A preprint is a type of preliminary medical research that […]